By Megan Stanley
For many years there has been media scrutiny on the risks
associated with breast implants. Recently, that attention focused
on breast implants provided by a French company called Poly Implant
Prothèse ("PIP").
The Therapeutic Goods Administration (the Australian Regulatory
Authority) recently published information regarding PIP breast
implants. Notification was given that silicone gel of an
industrial, rather than medical, grade (and which had not been
approved) had been used in some breast implants manufactured by
PIP.
Unused PIP breast implants were recalled from use in Australia
in early 2010. One question this raises is that if the recall was
overlooked and some of those implants were later surgically
implanted, then who is responsible for any later problems?
Certainly, this current issue highlights the need for any surgeon
who has used PIP breast implants to follow up with those
patients.